BAM
BBP icon

Byrne Asset Management’s Virtus Biotech ETF BBP Stock Holding History

Byrne Asset Management’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7K Hold
142
– – 0.01% 400
2026
Q1 		$11.8K Sell
142
-8
-5% -$658 0.01% 410
2025
Q4 		$12K Buy
+150
New +$11.4K 0.01% 409

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Byrne Asset Management's BBP Position: Q2 2026 in Review

Byrne Asset Management held its Virtus Biotech ETF (BBP) position steady in Q2 2026 at 142 shares worth $13.7K. The position accounts for 0.01% of the portfolio, ranked #400.

Byrne Asset Management first reported a position in BBP in Q4 2025 and has held it in 3 quarters since. 5 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • Byrne Asset Management held 142 shares of Virtus Biotech ETF worth $13.7K as of Q2 2026.
  • Byrne Asset Management left its Virtus Biotech ETF share count unchanged in Q2 2026.
  • Virtus Biotech ETF made up 0.01% of Byrne Asset Management's portfolio in Q2 2026, its #400 holding.
  • Byrne Asset Management first reported a position in Virtus Biotech ETF in Q4 2025 and has held it in 3 quarters since.
  • 5 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.